Effects of 4-methylpyrazole on ethanol neurobehavioral toxicity in CD-1 mice

Academic Emergency Medicine

Volumn 11, Issue 8, 2004, Pages 820-826

  Páez, Maria Ana ^a,b   Shannon, Michael ^a   Maher, Timothy ^a   Quang, Lawrence ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

4 methylpyrazole; alcohol dehydrogenase; ethanol; mice; neurobehavioral toxicity

Indexed keywords

4 METHYLPYRAZOLE; ALCOHOL; SODIUM CHLORIDE; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MEASUREMENT; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ALCOHOL-INDUCED DISORDERS, NERVOUS SYSTEM; ANIMALS; ANTIDOTES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; MALE; MICE; MOTOR ACTIVITY; MUSCULOSKELETAL EQUILIBRIUM; PLACEBOS; PROSPECTIVE STUDIES; PYRAZOLES; REFERENCE VALUES; REFLEX; ROTAROD PERFORMANCE TEST;

EID: 3242697013     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/j.aem.2004.03.007     Document Type: Article

References (27)

1. Shannon M. Toxicology reviews: fomepizole - a new antidote. Pediatr Emerg Care. 14:1998;170-172
2. Brent J., McMartin K., Phillips S., et al. Fomepizole for the treatment of ethylene glycol poisoning. N Engl J Med. 340:1999;832-838
3. Brent J., McMartin K., Phillips S., Aaron C., Kulig K. Methylpyrazole for toxic alcohols study group. Fomepizole for the treatment of methanol poisoning. N Engl J Med. 344:2001;424-429
4. Quang L.S., Shannon M.W., Woolf A.D., Desai M.C., Maher T.J. Pretreatment of CD-1 mice with 4-methylpyrazole blocks toxicity from the gamma-hydroxybutyrate precursor, 1,4-butanediol. Life Sci. 71:2002;771-778
5. Rustay N.R., Wahlsten D., Crabbe J.C. Assessment of genetic susceptibility to ethanol intoxication in mice. Proc Natl Acad Sci U S A. 100:2003;2917-2922
6. Ponomarev I., Crabbe J.C. A novel method to assess initial sensitivity and acute functional tolerance to hypnotic effects of ethanol. J Pharmacol Exp Ther. 302:2002;257-263
7. Tallarida R.J. Pharmacological calculation systems (computer software). 1986;Springer-Verlag, New York, NY
8. Theorell H., Yonetani T. Liver alcohol dehydrogenase-DPN-pyrazole complex: a model of a ternary intermediate in the enzyme reaction. Biochem Z. 338:1963;537-553
9. Lester D., Benson G.C. Alcohol oxidation in rats inhibited by pyrazole, oximes, and amides. Science. 169:1970;282-283
10. Goldberg L., Rydberg U. Inhibition of ethanol metabolism in vivo by administration of pyrazole. Biochem Pharmacol. 18:1969;1749-1762
11. Lester D., Keokosky Z., Felzenberg F. Effect of pyrazoles and other compounds on alcohol metabolism. Q J Stud Alcohol. 29:1968;449-454
12. Wilson W.L., Bottiglieri N.G. Phase I studies with pyrazole. Cancer Chemother Rep. 21:1962;137-141
13. Lelbach W.K. Liver cell necrosis in rats after prolonged ethanol ingestion under the influence of an alcohol dehydrogenase inhibitor. Specialia. 15:1969;816-818
14. Lieber C.S., Rubin E., DeCarli L.M., Misra P., Gang H. Effects of pyrazole on hepatic function and structure. Lab Invest. 22:1970;615-621
15. Theorell H., Yonetani T. On the effects of some heterocyclic compounds on the enzymatic activity of liver alcohol dehydrogenase. Acta Chem Scand. 23:1969;255-260
16. Reynier M. Pyrazole inhibition and kinetic studies of ethanol and retinol oxidation catalyzed by rat liver alcohol dehydrogenase. Acta Chem Scand. 23:1969;1119-1129
17. Kager L., Ericsson J.L. Long term toxicity study with alcohol and 4-methylpyrazole in rat. Acta Pathol Microbiol Scand [A]. 82:1974;534-538
18. Blomstrand R., Ellin A., Lof A., Ostling-Wintzell H. Biological effects and metabolic interactions after chronic and acute administration of 4-methylpyrazole and ethanol to rats. Arch Biochem Biophys. 199:1980;591-605
19. Li T.K., Theorell H. Human liver alcohol dehydrogenase: inhibition by pyrazole and pyrazole analogs. Acta Chem Scand. 23:1969;255-260
20. Sarkola T., Eriksson P. Effect of 4-methylpyrazole on endogenous plasma ethanol and methanol levels in humans. Alcohol Clin Exp Res. 25:2001;513-516
21. Connally H.E., Hamar D.W., Thrall M.A. Inhibition of canine and feline alcohol dehydrogenase activity by fomepizole. Am J Vet Res. 61:2000;450-455
22. McMartin K.E., Hedstrom K.G., Tolf B.R., Ostling-Wintzell H., Blomstrand R. Studies on the metabolic interaction between 4-methylpyrazole and methanol using the monkey as an animal model. Arch Biochem Biophys. 199:1980;606-614
23. Connally H.E., Thrall M.A., Forney S.D., Grauer G.F., Hamar D.W. Safety and efficacy of 4-methylpyrazole for treatment of suspected or confirmed ethylene glycol intoxication in dogs: 107 cases. JAMA. 209:1996;1880-1883
24. McMartin K.E., Collins T.D. Distribution of oral 4-methylpyrazole in the rat: inhibition of elimination by ethanol. J Toxicol Clin Toxicol. 26:1988;451-466
25. Jacobsen D., Sebastian C.S., Dies D.F., et al. Kinetic interactions between 4-methylpyrazole and ethanol in healthy humans. Alcohol Clin Exp Res. 20:1996;804-809
26. Cory-Slechta D.A. Behavioral measures of neurotoxicity. Neurotoxicology. 10:1989;271-295
27. Tilson H.A., Moser V.C. Comparison of screening approaches. Neurotoxicology. 13:1992;1-13